Status:
UNKNOWN
Laser Therapy on Tension-type Cephalea and Orofacial Pain in Post-covid-19 Patients
Lead Sponsor:
University of Nove de Julho
Conditions:
Tension-Type Headache
Orofacial Pain
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Considering the auxiliary potential effect of photobiomodulation in controlling persistent CTT and TMD-related pain in patients who have been diagnosed with COVID-19, and are recovered from the viral ...
Detailed Description
Orofacial pain and tensional cephalea were symptoms commonly reported in COVID-19 patients, even after recovery, and were considered chronic pain in these cases. The pain control, in these cases, is m...
Eligibility Criteria
Inclusion
- Individuals of both sexes, between the ages of 19 and 65, complaining of persistent orofacial pain or functional-type cephalea, for more than 3 months.
- Individuals diagnosed with COVID-19, confirmed by RT-PCR for SARS-CoV-2 already recovered, at least 30 days after infection.
Exclusion
- Individuals with diagnoses of neuropathies and headaches other than tension-type headache
- Physical or intellectual incapacity to answer the survey questionnaires; illiterate; diabetics, pacemakers, and pregnant women.
- Individuals who report photosensitivity to laser.
Key Trial Info
Start Date :
May 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05430776
Start Date
May 10 2022
End Date
September 20 2023
Last Update
June 24 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nove de Julho Univ
São Paulo, São Paulo, Brazil, 18133-399
2
Lara Motta
São Roque, São Paulo, Brazil, 18133-399